Novellus gets new name, new CEO as it completes pivot
22 Feb 2021 //
FIERCEBIOTECH
Novellus and Tempus Announce Collaboration to Accelerate Clinical Trial
23 Nov 2020 //
BUSINESSWIRE
Novellus Therapeutics Licenses Induced Mesenchymal Stem Cells (iMSCs)
13 Oct 2020 //
PRNEWSWIRE
Novellus Closes $57M Series C Financing
21 Sep 2020 //
BUSINESSWIRE
Novellus Executes Exclusive Worldwide License Agreement Plexxikon for PLX8394
03 Jun 2020 //
BUSINESSWIRE
Daiichi`s biotech unit Plexxikon signs away BRAF cancer drug
03 Jun 2020 //
FIERCE BIOTECH